All tags Immun-oncology Biomarker Platforms and Biomarkers in Immuno-Oncology

Biomarker Platforms and Biomarkers in Immuno-Oncology

​​​​This exciting one-day meeting will highlight new and emerging discoveries in biomarkers, in depth observation of immune activity and pathways, and an additional focus on researchers utilizing the Fireplex® profiling platform. 

Last minute attendance: Registration is open until midnight February 28! Do not miss out and register below. 

Merck Auditorium,
Longwood Medical Area,
Boston, Massachusetts 
March 1, 2018


Participation is free, however registration is required. Places are allocated on a 'first come, first served' basis. Book early to avoid disappointment!

Registration closes: Midnight February 28, 2018

Check out our final meeting program here

Check out the meeting poster

Confirmation note: All registered attendees will receive an email confirmation from within 48 hours of registering. If you do not receive this confirmation email, please contact the Abcam Events Team to confirm your registration.

Join us for this collaborative and engaging event that will provide insights into new techniques and markers, as well as how FirePlex® is being applied in immuno-oncology research.


  • Dr. George Calin (MD Anderson Cancer Center)
  • Dr. Houssein Abdul Sater (NIH, NCI)
    Advances and hurdles in Tumor Immune Microenvironment (TIME) multispectral imaging
  • Dr. Ignacio Wistuba (MD Anderson Cancer Center)
    Strategy for predictive biomarkers development for immunotherapy
  • ​Michael Silverman (Massachusetts General Hospital)
    The association between miRNA profiles and inflammation with electrical and mechanical remodeling post Myocardial Infarction 
  • Michael Johnson, (Visikol)
    ​3D Cell Cultures and Tissue Clearing: A High Content Confocal Platform for the Complete 3D Characterization of Advanced Cell Models​
  • Girijal Goyal  (Wyss Institute)
    An organ-on-chip model of human tertiary lymphoid follicles
  • Nicholas Farina (University of Vermont)
    Development of a predictive microRNA signature for breast cancer risk among high-risk women


The meeting will be held at the Merck auditorium in Boston.

Merck Auditorium
33 Avenue Louis Pasteur
Boston, 02115, MA

* Important note:
Abcam does not have an affiliated hotel agency for this event.
Please be careful of direct approaches from companies offering hotel reservations for this event. Reservations made by unaffiliated organizations may appear to be for lower rates, however they may be illegitimate, have unreasonable cancellation or change penalties, or be completely non-refundable. Please be aware of, and report any unauthorized solicitation to Abcam

Call for Abstracts

​​Short talk and poster presentation opportunities are available. ​Abstracts can be submitted during online registration. Everyone, especially young researchers and students, are encouraged to submit their exciting new unpublished work for presentation. Abstracts submitted after time of registration can be sent to


Program starts Thursday, March 1st, 09:00AM- 05:00PM

*Note, these times are provisional and subject to change

Terms and Conditions

  • Delegates are advised to ensure they have adequate travel insurance to cover their attendance at the conference in case of incident, or cancellation due to circumstances beyond Abcam's control..
  • Substitute delegates can be made at any time by contacting the Abcam Events Team.

  • Frequently asked questions

How can I submit an abstract?​
Abstracts can be submitted through the online registration process.

  • What happens if I register but cannot attend?
    Substitute delegates can be nominated at any time by contacting the Abcam Events Team.
  • Are there exhibition and/or sponsorship opportunities?
    Sponsorship and exhibition opportunities are available for this conference. If you are interested in sponsoring or exhibiting, please email the Abcam Events Team for more information.
  • Have a question?